Corrigendum to "WCN24-1267 EMPAGLIFLOZIN IMPROVES VITALITY AND PROTECT FROM ADVANCED GLYCATION END PRODUCTS IN ENDOTHELIAL CELLS" [ Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Page S637]

Pietro Iulianiello,Davide Viggiano,Margherita Borriello,Rashmi Joshi,Alessandra Perna,Diego Ingrosso,Angela Vastante
DOI: https://doi.org/10.1016/j.ekir.2024.04.052
2024-04-29
Abstract:[This corrects the article DOI: 10.1016/j.ekir.2024.02.1344.].
What problem does this paper attempt to address?